e6446 Search Results


94
New England Biolabs multiplex oligonucleotides
Multiplex Oligonucleotides, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multiplex oligonucleotides/product/New England Biolabs
Average 94 stars, based on 1 article reviews
multiplex oligonucleotides - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
MedChemExpress e6446 dihydrochloride hy 12756a
E6446 Dihydrochloride Hy 12756a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e6446 dihydrochloride hy 12756a/product/MedChemExpress
Average 93 stars, based on 1 article reviews
e6446 dihydrochloride hy 12756a - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Selleck Chemicals s6719
S6719, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/s6719/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
s6719 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Selleck Chemicals tlr9 inhibitor e6446
<t>TLR9</t> acts downstream of IL-1α to mediate NET formation and hepatocyte apoptosis in ASH. (A) Volcano plot of RNA-seq data showing differentially expressed genes in neutrophils treated with IL-1α compared to untreated controls. TLR9 was among the significantly upregulated genes (red dots, n = 3 per group). (B) KEGG pathway enrichment analysis of 46 upregulated genes identified Toll-like receptor signaling as the most enriched pathway. (C) Experimental timeline. Mice were pair-fed or fed an ethanol-containing Lieber-DeCarli diet for 10 days. <t>E6446</t> (a TLR9 inhibitor, 20 mg/kg, orally [p.o.]) was administered 24 and 15 hours prior to euthanasia. (D, E) Serum ALT and AST levels were significantly reduced in EtOH-fed mice treated with E6446 compared to untreated ASH mice (n = 6 per group). (F, G) Representative H&E and Oil Red O staining of liver sections showing improved histology and reduced lipid accumulation in the E6446 group. Scale bar = 100 μm. (H) Immunofluorescence staining of liver tissues showing reduced intrahepatic NET formation (MPO: red; CitH3: green; DAPI: blue) after E6446 treatment. Original images, scale bar = 50 μm; magnified insets, scale bar = 10 μm. (I, J) Representative TUNEL staining and quantification of TUNEL-positive areas showed a reduction in hepatocyte apoptosis in E6446-treated mice (n = 6 per group). Scale bar = 100 μm. (K) Western blot and densitometric quantification of hepatic TLR9, CitH3, and Cle-CASP3 levels. E6446 treatment significantly reduced expression of all three proteins (n = 6 per group). Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant. Statistical comparisons were performed using one-way ANOVA followed by Tukey's multiple comparisons test.
Tlr9 Inhibitor E6446, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr9 inhibitor e6446/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
tlr9 inhibitor e6446 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
MedChemExpress tlr9 inhibitor e6446
The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the <t>TLR9</t> inhibitor <t>E6446</t> (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).
Tlr9 Inhibitor E6446, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr9 inhibitor e6446/product/MedChemExpress
Average 93 stars, based on 1 article reviews
tlr9 inhibitor e6446 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
TargetMol e6446
The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the <t>TLR9</t> inhibitor <t>E6446</t> (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).
E6446, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e6446/product/TargetMol
Average 93 stars, based on 1 article reviews
e6446 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Merck KGaA e6446-02
The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the <t>TLR9</t> inhibitor <t>E6446</t> (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).
E6446 02, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e6446-02/product/Merck KGaA
Average 90 stars, based on 1 article reviews
e6446-02 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cayman Chemical e6446 cayman chemical 37296
The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the <t>TLR9</t> inhibitor <t>E6446</t> (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).
E6446 Cayman Chemical 37296, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e6446 cayman chemical 37296/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
e6446 cayman chemical 37296 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Eisai Inc e6446
Figure 7 | IFNc-dependent chemokine expression and emergence of CD45high haematopoietic cells. CCL2, CCL3, CCL4, CCL5, CXCL9, CXCL10 and IFNg mRNA expression was analysed in brain tissue of uninfected or PbA-infected (a) IFNg / and C57BL/6 mice, as well as (b) C57BL/6 mice treated from day 1 to 3 post infection with vehicle or <t>E6446</t> (120 mg kg 1 per day), as indicated. The mRNA levels were analysed by quantitative PCR and results presented after normalization with b2-microglobulin mRNA. (c) Flow cytometric analysis of brain MO-DCs first selected on CD45high, gated on CD3 CD8 and then CD11b þLy6c þ (CD11c þDC-SIGN þ) from uninfected and PBA-infected WT, IFNg / and WT mice treated with E6446 7 days post infection. The numbers of both CD45highCD8 þCD3 þ and CD45highCD8 CD3 CD11c þCD11b þDC-SIGNhighLy6c þ cells are significantly decreased in the brain of infected IFNg / and E6446-treated mice. Differences considered statistically significant when *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001 as indicated by two-way analysis of variance analysis (values are means±s.d.).
E6446, supplied by Eisai Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e6446/product/Eisai Inc
Average 86 stars, based on 1 article reviews
e6446 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

N/A
A novel synthetic antagonist for nucleic acid-sensing TLRs
  Buy from Supplier

N/A
A novel synthetic antagonist for nucleic acid-sensing TLRs
  Buy from Supplier


Image Search Results


TLR9 acts downstream of IL-1α to mediate NET formation and hepatocyte apoptosis in ASH. (A) Volcano plot of RNA-seq data showing differentially expressed genes in neutrophils treated with IL-1α compared to untreated controls. TLR9 was among the significantly upregulated genes (red dots, n = 3 per group). (B) KEGG pathway enrichment analysis of 46 upregulated genes identified Toll-like receptor signaling as the most enriched pathway. (C) Experimental timeline. Mice were pair-fed or fed an ethanol-containing Lieber-DeCarli diet for 10 days. E6446 (a TLR9 inhibitor, 20 mg/kg, orally [p.o.]) was administered 24 and 15 hours prior to euthanasia. (D, E) Serum ALT and AST levels were significantly reduced in EtOH-fed mice treated with E6446 compared to untreated ASH mice (n = 6 per group). (F, G) Representative H&E and Oil Red O staining of liver sections showing improved histology and reduced lipid accumulation in the E6446 group. Scale bar = 100 μm. (H) Immunofluorescence staining of liver tissues showing reduced intrahepatic NET formation (MPO: red; CitH3: green; DAPI: blue) after E6446 treatment. Original images, scale bar = 50 μm; magnified insets, scale bar = 10 μm. (I, J) Representative TUNEL staining and quantification of TUNEL-positive areas showed a reduction in hepatocyte apoptosis in E6446-treated mice (n = 6 per group). Scale bar = 100 μm. (K) Western blot and densitometric quantification of hepatic TLR9, CitH3, and Cle-CASP3 levels. E6446 treatment significantly reduced expression of all three proteins (n = 6 per group). Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant. Statistical comparisons were performed using one-way ANOVA followed by Tukey's multiple comparisons test.

Journal: International Journal of Biological Sciences

Article Title: Neutrophil Recruitment via Hepatocyte IL-1α Drives NETs-Mediated AIM2 Hepatocyte Apoptosis in Alcohol-associated steatohepatitis

doi: 10.7150/ijbs.121255

Figure Lengend Snippet: TLR9 acts downstream of IL-1α to mediate NET formation and hepatocyte apoptosis in ASH. (A) Volcano plot of RNA-seq data showing differentially expressed genes in neutrophils treated with IL-1α compared to untreated controls. TLR9 was among the significantly upregulated genes (red dots, n = 3 per group). (B) KEGG pathway enrichment analysis of 46 upregulated genes identified Toll-like receptor signaling as the most enriched pathway. (C) Experimental timeline. Mice were pair-fed or fed an ethanol-containing Lieber-DeCarli diet for 10 days. E6446 (a TLR9 inhibitor, 20 mg/kg, orally [p.o.]) was administered 24 and 15 hours prior to euthanasia. (D, E) Serum ALT and AST levels were significantly reduced in EtOH-fed mice treated with E6446 compared to untreated ASH mice (n = 6 per group). (F, G) Representative H&E and Oil Red O staining of liver sections showing improved histology and reduced lipid accumulation in the E6446 group. Scale bar = 100 μm. (H) Immunofluorescence staining of liver tissues showing reduced intrahepatic NET formation (MPO: red; CitH3: green; DAPI: blue) after E6446 treatment. Original images, scale bar = 50 μm; magnified insets, scale bar = 10 μm. (I, J) Representative TUNEL staining and quantification of TUNEL-positive areas showed a reduction in hepatocyte apoptosis in E6446-treated mice (n = 6 per group). Scale bar = 100 μm. (K) Western blot and densitometric quantification of hepatic TLR9, CitH3, and Cle-CASP3 levels. E6446 treatment significantly reduced expression of all three proteins (n = 6 per group). Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant. Statistical comparisons were performed using one-way ANOVA followed by Tukey's multiple comparisons test.

Article Snippet: To evaluate the effect of NET-DNA and IL-1α signaling, mice were treated with DNase I (10 U in 100 μL 0.9% NaCl, Intraperitoneal injection (i.p.); Cat. No. EN0521, Thermo Fisher Scientific/Fermentas, USA) or the TLR9 inhibitor E6446 (20 mg/kg, Oral administration (p.o.); Cat. No. S6719, Selleck, China) at 24 and 15 hours prior to tissue harvest.

Techniques: RNA Sequencing, Staining, Immunofluorescence, TUNEL Assay, Western Blot, Expressing

Schematic model depicting the intercellular signaling axis between ethanol-injured hepatocytes and neutrophils during ASH progression. Ethanol exposure triggers IL-1α release from hepatocytes, acting as a key damage-associated molecular pattern (DAMPs). This hepatocyte-derived IL-1α upregulates TLR9 expression in recruited neutrophils (①), thereby promoting a phenotypic switch toward a SiglecF⁺ NET-prone state (②). Enhanced NET formation follows (③), releasing extracellular NET-DNA, which is subsequently internalized by hepatocytes. Intracellular NET-DNA activates the cytosolic DNA sensor AIM2, leading to caspase-3 cleavage and hepatocyte apoptosis. This positive feedback loop sustains sterile hepatic inflammation and accelerates ASH pathogenesis.

Journal: International Journal of Biological Sciences

Article Title: Neutrophil Recruitment via Hepatocyte IL-1α Drives NETs-Mediated AIM2 Hepatocyte Apoptosis in Alcohol-associated steatohepatitis

doi: 10.7150/ijbs.121255

Figure Lengend Snippet: Schematic model depicting the intercellular signaling axis between ethanol-injured hepatocytes and neutrophils during ASH progression. Ethanol exposure triggers IL-1α release from hepatocytes, acting as a key damage-associated molecular pattern (DAMPs). This hepatocyte-derived IL-1α upregulates TLR9 expression in recruited neutrophils (①), thereby promoting a phenotypic switch toward a SiglecF⁺ NET-prone state (②). Enhanced NET formation follows (③), releasing extracellular NET-DNA, which is subsequently internalized by hepatocytes. Intracellular NET-DNA activates the cytosolic DNA sensor AIM2, leading to caspase-3 cleavage and hepatocyte apoptosis. This positive feedback loop sustains sterile hepatic inflammation and accelerates ASH pathogenesis.

Article Snippet: To evaluate the effect of NET-DNA and IL-1α signaling, mice were treated with DNase I (10 U in 100 μL 0.9% NaCl, Intraperitoneal injection (i.p.); Cat. No. EN0521, Thermo Fisher Scientific/Fermentas, USA) or the TLR9 inhibitor E6446 (20 mg/kg, Oral administration (p.o.); Cat. No. S6719, Selleck, China) at 24 and 15 hours prior to tissue harvest.

Techniques: Derivative Assay, Expressing, Sterility

The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the TLR9 inhibitor E6446 (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).

Journal: Journal of Virology

Article Title: African swine fever virus infection enhances CD14-dependent phagocytosis of porcine alveolar macrophages to promote bacterial uptake and apoptotic body-mediated viral transmission

doi: 10.1128/jvi.00690-25

Figure Lengend Snippet: The upregulated CD14 in bystander PAMs facilitates viral transmission by enabling the phagocytosis of more ASFV-containing apoptotic bodies. ( A ) The supernatants from PAMs infected with ASFV (MOI 1) at 3, 6, 12, and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and then added to untreated PAMs for culturing for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of three independent experiments ± SD). ( B ) The ASFV-removed supernatants from PAMs at 12 and 24 hpi were cultured with untreated PAMs for 3 h, respectively, and then infected with E. coli -EGFP (MOI 10) for 2 h. The “positive CTRL group” represents PAMs that were infected with unfiltered ASFV before bacterial infection. Flow cytometry was used to detect the phagocytic rate of PAMs (mean of three independent experiments ± SD). hpt, hours post-treatment. ( C ) PAMs were incubated with different cytokines at a concentration of 1 ng/mL (20 ng/mL for GM-CSF) for 3 h. The relative level of CD14 mRNA in PAMs was analyzed by qPCR (mean of four independent experiments ± SD). ( D ) The supernatants from PAMs infected with ASFV (MOI 1) at 12 and 24 hpi were collected, filtered through a 0.1 µm PVDF filter to remove ASFV, and extracted viral DNA. The level of CP204L was analyzed by qPCR, and the copy number was calculated using a standard curve (mean of three independent experiments ± SD). ( E ) PAMs were treated for 3 h with the ASFV-removed supernatant that was treated with DNase (4 U/100 µL) at 37°C for 30 min. The expression of CD14 was detected by flow cytometry (mean of three independent experiments ± SD). ( F, G ) PAMs were pre-treated with the TLR9 inhibitor E6446 (10 µM) for 1 h, and then with extracted viral DNA (24 hpi) for 3 h. The DNA extracted from the filtered supernatant of CTRL PAMs was used as the control. All groups were infected with E. coli -EGFP (MOI 10) for 2 h. CD14 MFI ( F ) and phagocytosis of E. coli -EGFP ( G ) were analyzed by flow cytometry (mean of three independent experiments ± SD). ( H ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. ApoBDs were observed by IFA. Nuclei were stained with DAPI. Scale bar, 100 µm. ( I ) PAMs were infected with ASFV-mCherry (MOI 2) for 24 hpi. Isolated ApoBDs were observed by IFA. Phosphatidylserine (PS) was stained with Annexin V-Alexa 488 at room temperature for 15 min. The arrows point to only a subset of representative ApoBDs containing ASFV-mCherry. Scale bar, 25 µm. ( J ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 1 h. The DNA was extracted, and the level of mCherry was analyzed by qPCR (mean of three independent experiments ± SD). ( K ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The infection efficiency of PAMs was observed by IFA. Nuclei were stained with DAPI. Representative data from multiple experiments are shown. Scale bar, 100 µm. ( L ) Calculate the percentage of infected PAMs (mean ± SD of 10 samples). ( M ) PAMs were treated with siCD14 for 24 h, then incubated with ASFV-removed supernatant for another 3 h, and subsequently infected with ApoBDs-mCherry for 12 h. The titer of ASFV in PAMs was detected using TCID 50 (mean of three independent experiments ± SD). ( N ) The relative levels of CD14 mRNA in PAMs at 3 hpi were analyzed by qPCR. The control inoculum was harvested from PAMs that had been induced to apoptosis by UV irradiation for 60 min. The supernatant and ApoBDs were isolated from it using the same method as the ASFV inoculum. The supernatant was used as the control for infection with ASFV particles, and the ApoBDs were used as the control for infection with ApoBDs (containing ASFV) (mean of three independent experiments ± SD).

Article Snippet: NF-κB inhibitor BAY 11-7082 (HY-13453), cGAS inhibitor RU.521 (HY-114180), STING inhibitor C176 (HY-112906), TLR9 inhibitor E6446 (HY-12756), and bacterial adhesion inhibitor Sibofimloc (HY-12820) were purchased from MedChemExpress (Monmouth Junction, NJ, USA).

Techniques: Transmission Assay, Infection, Cell Culture, Flow Cytometry, Incubation, Concentration Assay, Expressing, Control, Staining, Isolation, Irradiation

Model of ASFV infection enhances the phagocytosis of PAMs. In the early stages of ASFV internalization, the viral dsDNA released into the cytoplasm is recognized by the cGAS-STING pathway, inducing the downstream nuclear translocation of NF-κB p65. This ultimately activates the transcription and expression of CD14 in PAMs. Free viral DNA released from infected PAMs enters bystander PAMs and enhances CD14 expression via the TLR9 pathway. The high expression of CD14 on the cell membrane surface facilitates phagocytosis in PAMs and induces a stronger transcription of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α). The upregulation of CD14 in bystanders enhances the phagocytosis of ApoBDs-containing ASFV, which benefits the transmission of the virus.

Journal: Journal of Virology

Article Title: African swine fever virus infection enhances CD14-dependent phagocytosis of porcine alveolar macrophages to promote bacterial uptake and apoptotic body-mediated viral transmission

doi: 10.1128/jvi.00690-25

Figure Lengend Snippet: Model of ASFV infection enhances the phagocytosis of PAMs. In the early stages of ASFV internalization, the viral dsDNA released into the cytoplasm is recognized by the cGAS-STING pathway, inducing the downstream nuclear translocation of NF-κB p65. This ultimately activates the transcription and expression of CD14 in PAMs. Free viral DNA released from infected PAMs enters bystander PAMs and enhances CD14 expression via the TLR9 pathway. The high expression of CD14 on the cell membrane surface facilitates phagocytosis in PAMs and induces a stronger transcription of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α). The upregulation of CD14 in bystanders enhances the phagocytosis of ApoBDs-containing ASFV, which benefits the transmission of the virus.

Article Snippet: NF-κB inhibitor BAY 11-7082 (HY-13453), cGAS inhibitor RU.521 (HY-114180), STING inhibitor C176 (HY-112906), TLR9 inhibitor E6446 (HY-12756), and bacterial adhesion inhibitor Sibofimloc (HY-12820) were purchased from MedChemExpress (Monmouth Junction, NJ, USA).

Techniques: Infection, Translocation Assay, Expressing, Membrane, Transmission Assay, Virus

Figure 7 | IFNc-dependent chemokine expression and emergence of CD45high haematopoietic cells. CCL2, CCL3, CCL4, CCL5, CXCL9, CXCL10 and IFNg mRNA expression was analysed in brain tissue of uninfected or PbA-infected (a) IFNg / and C57BL/6 mice, as well as (b) C57BL/6 mice treated from day 1 to 3 post infection with vehicle or E6446 (120 mg kg 1 per day), as indicated. The mRNA levels were analysed by quantitative PCR and results presented after normalization with b2-microglobulin mRNA. (c) Flow cytometric analysis of brain MO-DCs first selected on CD45high, gated on CD3 CD8 and then CD11b þLy6c þ (CD11c þDC-SIGN þ) from uninfected and PBA-infected WT, IFNg / and WT mice treated with E6446 7 days post infection. The numbers of both CD45highCD8 þCD3 þ and CD45highCD8 CD3 CD11c þCD11b þDC-SIGNhighLy6c þ cells are significantly decreased in the brain of infected IFNg / and E6446-treated mice. Differences considered statistically significant when *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001 as indicated by two-way analysis of variance analysis (values are means±s.d.).

Journal: Nature communications

Article Title: Splenic differentiation and emergence of CCR5 + CXCL9 + CXCL10 + monocyte-derived dendritic cells in the brain during cerebral malaria.

doi: 10.1038/ncomms13277

Figure Lengend Snippet: Figure 7 | IFNc-dependent chemokine expression and emergence of CD45high haematopoietic cells. CCL2, CCL3, CCL4, CCL5, CXCL9, CXCL10 and IFNg mRNA expression was analysed in brain tissue of uninfected or PbA-infected (a) IFNg / and C57BL/6 mice, as well as (b) C57BL/6 mice treated from day 1 to 3 post infection with vehicle or E6446 (120 mg kg 1 per day), as indicated. The mRNA levels were analysed by quantitative PCR and results presented after normalization with b2-microglobulin mRNA. (c) Flow cytometric analysis of brain MO-DCs first selected on CD45high, gated on CD3 CD8 and then CD11b þLy6c þ (CD11c þDC-SIGN þ) from uninfected and PBA-infected WT, IFNg / and WT mice treated with E6446 7 days post infection. The numbers of both CD45highCD8 þCD3 þ and CD45highCD8 CD3 CD11c þCD11b þDC-SIGNhighLy6c þ cells are significantly decreased in the brain of infected IFNg / and E6446-treated mice. Differences considered statistically significant when *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001 as indicated by two-way analysis of variance analysis (values are means±s.d.).

Article Snippet: EISAI Pharmaceuticals has kindly provided E6446 under an MTA.

Techniques: Expressing, Infection, Real-time Polymerase Chain Reaction